BATON ROUGE – Critics are questioning why Dsuvia is necessary. It's a new opioid and analgesic that has recently been approved by the FDA, but many people do not agree and think it's a terrible mistake.
"We are probably in the midst of the worst epidemic of the country's opiate epidemic, perhaps killing and wounding more people than any other infectious disease in the world," said Coroner Beau Clark.
East Baton Rouge Parish Coroner Dr.Beau Clark believes that at least 72 deaths have occurred this year in this parish only from the fatal effects of opioid use.
"This seems like a blatant disregard for human life, and we are talking about matter. Why do opioids kill people when they have problems with what they have, and do they need more?
According to the FDA, there are strict guidelines for drugs in the mouth. Only available in hospitals, surgical centers and emergency rooms. Dsuvia should not be used for more than 72 hours and not at retail pharmacies.
They say this is a drug that will be administered only in a medical facility for a very short period of time in a highly controlled environment. It's great if it's true. However, in the latter part of the statement, they also say that they are contradictions themselves because they were developed with the Department of Defense.
Dr. Smith Gottlieb said in a statement from the FDA committee that "this opioid formulation was a top priority for the US Department of Defense, along with Duvavia's unique delivery system." Battlefield, but Dr. Clark will not buy it.
"Soldiers are protecting our country, and if injuries get injured, the longer it takes to get injured and ultimately treated, the longer you have to have a mechanism to manage the pain," Clark said.
The serious risks of using Dsuvia include respiratory depression, coma, and even death, not to mention addictive.
"Having a strong and powerful opioid is actually the wrong direction and it definitely sends the wrong message." He added in a Dsuvia statement to Dr. Guitlieb: "We will not avoid what we consider to be a source of genuine fundamental discontent among these criticism critics. The question is a massive crisis of addiction. "
Gottlieb said the question will be addressed openly and directly. Dsuvia is expected to reach $ 1.1 billion in annual sales, but Clark is more interested in a life he can lose in the future.
"It will be another year of increasing the number of opioids compared to last year, the end is invisible, and we think that a much more powerful opioid causes more and more problems when we do this," Clark said.
For more information about Dsuvia, click here.